Novi vs SkinnyRx: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Novi beats SkinnyRx overall, scoring 7.8/10 vs 7.3/10. Novi is more affordable at $133/mo vs $199/mo. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa. Choose SkinnyRx for users who want flexibility in compounded glp-1 medication fo.
A side-by-side comparison of Novi and SkinnyRx covering pricing, scores, medication types, insurance, and more to help you decide.
Novi
#14 of 47Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing — medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.
Visit NoviSkinnyRx
#36 of 47Direct-to-consumer telehealth platform offering compounded GLP-1 medications across five formats — injectable and sublingual semaglutide, semaglutide tablets, and tirzepatide as either injectable or tablets. Operated by Lean Rx, Inc. (Sacramento, CA). Compounded only — does not prescribe brand-name Wegovy/Zepbound/Ozempic/Mounjaro. Cash-pay only with HSA/FSA accepted; does not bill insurance. 4,100+ Trustpilot reviews at 4.8 stars.
Visit SkinnyRx| Feature | Novi | SkinnyRx |
|---|---|---|
| Our Score | 7.8/10 | 7.3/10 |
| Starting Price | $133/mo | $199/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer | Users who want flexibility in compounded GLP-1 medication format (injectable, sublingual, or tablet) at a mid-tier price point |
| Ranking | #14 | #36 |
Pros & Cons Compared
Novi
Pros
- +Six disclosed clinicians on staff — Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP) — more named providers than most compounded-only platforms publish
- +Month-to-month billing with no minimum commitment — cancel before any renewal date with no early-termination penalty
- +Aggressive promotional pricing on the offer landing — $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
- +Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
- +Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
- +100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal
Cons
- −Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
- −Founding year, headquarters city, and corporate ownership are not publicly disclosed
- −Promotional $99-$133 pricing applies to the introductory offer landing only — standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
- −Once medication is dispensed/shipped, prescriptions cannot be returned or refunded — typical for compounded telehealth but worth understanding
- −Lab requirements before prescribing are not disclosed on public pages — unclear whether baseline bloodwork is required
- −Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout
SkinnyRx
Pros
- +Five medication formats — the broadest compounded-GLP-1 menu in DTC telehealth, including the rare oral tirzepatide tablet that almost no competitor offers
- +$199/mo entry price for both injectable and sublingual semaglutide is competitive in the mid-tier compounded segment
- +Fast onboarding: 5–10 minute online questionnaire, physician review in 24–48 hours, medication delivered in 3–7 business days with temperature-controlled shipping
- +4,100+ Trustpilot reviews at 4.8 stars — among the strongest aggregate social-proof signals in the GLP-1 telehealth category
Cons
- −No brand-name FDA-approved options (Wegovy, Zepbound, Ozempic, Mounjaro) — compounded-only model limits patients who want or need an FDA-approved finished product
- −Limited public transparency: founders, executive team, medical director, and specific compounding-pharmacy partners are not named on the public site
- −Cash-pay only — does not bill commercial insurance, Medicare, or Medicaid (HSA/FSA payments accepted)
- −Independent reviews flag inconsistent customer-service responsiveness, which is a real concern for a medication that requires titration support and dose-adjustment dialogue
Our Verdict
Novi edges out SkinnyRx with a score of 7.8/10 vs 7.3/10. If budget is your priority, Novi starts at $133/mo compared to SkinnyRx's $199/mo. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer. Choose SkinnyRx if you want: users who want flexibility in compounded glp-1 medication format (injectable, sublingual, or tablet) at a mid-tier price point.